KR100859984B1 - Submerged-Liquid Culture Extract of Fomitopsis pinicola Mycelium and Composition Comprising the Same for Lowering Blood Sugar - Google Patents

Submerged-Liquid Culture Extract of Fomitopsis pinicola Mycelium and Composition Comprising the Same for Lowering Blood Sugar Download PDF

Info

Publication number
KR100859984B1
KR100859984B1 KR1020070034998A KR20070034998A KR100859984B1 KR 100859984 B1 KR100859984 B1 KR 100859984B1 KR 1020070034998 A KR1020070034998 A KR 1020070034998A KR 20070034998 A KR20070034998 A KR 20070034998A KR 100859984 B1 KR100859984 B1 KR 100859984B1
Authority
KR
South Korea
Prior art keywords
extract
medium
mycelium
pine
culture
Prior art date
Application number
KR1020070034998A
Other languages
Korean (ko)
Other versions
KR20070080606A (en
Inventor
오승희
김순동
이상일
이현구
Original Assignee
유진바이오팜영농조합법인
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 유진바이오팜영농조합법인 filed Critical 유진바이오팜영농조합법인
Priority to KR1020070034998A priority Critical patent/KR100859984B1/en
Publication of KR20070080606A publication Critical patent/KR20070080606A/en
Application granted granted Critical
Publication of KR100859984B1 publication Critical patent/KR100859984B1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06Fungi, e.g. yeasts
    • A61K36/07Basidiomycota, e.g. Cryptococcus
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30Extraction of the material
    • A61K2236/33Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
    • A61K2236/331Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation, decoction

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Mycology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Food Science & Technology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Nutrition Science (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Polymers & Plastics (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

본 발명은 귤피(citrus peel) 또는 녹차(green tea) 추출물을 함유한 배지에서 배양한 소나무잔나비버섯 배양균사체 추출물 및 그를 함유한 혈당강하용 조성물에 관한 것이다. 본 발명의 소나무잔나비버섯 배양균사체 추출물을 이용하면, 종래의 감자 배지를 사용하여 배양한 배양균사체 추출물의 혈당저하 효과보다 현저히 큰 효과를 나타낼 수 있어서, 당뇨환자를 위한 기능성 식품에 널리 활용될 수 있을 것이다.The present invention relates to a pine myrtle mushroom culture mycelium extract cultured in a medium containing citrus peel or green tea extract and a blood glucose lowering composition containing the same. By using the pine myrtle mushroom culture mycelium extract of the present invention, it can exhibit a significantly greater effect than the hypoglycemic effect of the culture mycelium extract cultured using a conventional potato medium, can be widely used in functional foods for diabetic patients will be.

소나무잔나비버섯 배양균사체 추출물, 녹차 배지, 귤피 배지, 혈당강하용 조성물 Pine myrtle mushroom culture mycelia extract, green tea medium, tangerine medium, hypoglycemic composition

Description

소나무잔나비버섯 배양균사체 추출물 및 그를 함유한 혈당강하용 조성물{Submerged-Liquid Culture Extract of Fomitopsis pinicola Mycelium and Composition Comprising the Same for Lowering Blood Sugar}Submerged-Liquid Culture Extract of Fomitopsis pinicola Mycelium and Composition Comprising the Same for Lowering Blood Sugar}

본 발명은 귤피(citrus peel) 또는 녹차(green tea) 추출물을 함유한 배지에서 배양한 소나무잔나비버섯 배양균사체 추출물 및 그를 함유한 혈당강하용 조성물에 관한 것이다. 좀 더 구체적으로, 감자 배지와 같은 일반적인 합성배지로 배양한 배양균사체 추출물보다 혈당저하 효과가 우수하고, 혈청지질 개선효과 및 항산화 효과를 나타내는 소나무잔나비버섯 배양균사체 추출물 및 그를 함유한 혈당강하용 조성물에 관한 것이다. The present invention relates to a pine myrtle mushroom culture mycelium extract cultured in a medium containing citrus peel or green tea extract and a blood glucose lowering composition containing the same. More specifically, the extract of pine myrtle mushroom culture mycelium and the hypoglycemic composition containing the same, which have better hypoglycemic effect and exhibit serum lipid improving effect and antioxidant effect than the culture mycelium extract cultured with a general synthetic medium such as potato medium. It is about.

경제성장에 따른 식생활 문화의 변화와 영양과다로 인해 암, 뇌졸중, 고혈압 및 당뇨병과 같은 퇴행성 성인병의 발병율이 증가되고 있다. 이 중, 당뇨병은 우리나라 전체 인구의 3% 이상, 특히, 65세 성인의 경우에는 6.5% 이상의 유병율을 나타내면서 매년 심각하게 증가하고 있으며, 그 기전이 정확히 밝혀지진 않았으나 생체의 당 이용능력의 감퇴로 인해 혈중에 존재하는 과잉의 당이 심장순환계 질환 이나 신경계 및 신장 장애를 초래하는 질환으로 여러가지 면역기능 이상과 합병증을 유발시키기 때문에 약물치료와 음식조절을 통해 평생을 치료해야 하는 것으로 알려져 있다. Due to economic growth and changes in dietary culture and overnutrition, the incidence of degenerative adult diseases such as cancer, stroke, high blood pressure and diabetes is increasing. Among them, diabetes is increasing every year with a prevalence rate of more than 3% of the total population of Korea, especially for adults aged 65 years or more, and more than 6.5%. Excess sugar in the blood causes cardiac circulatory disorders, neurological and renal disorders and causes various immune dysfunctions and complications.

또한, 당뇨병은 췌장의 랑게르한스섬의 β세포의 손상으로 인해 여러가지 면역 관련 사이토카인이 증가되는 인슐린 의존형과 비만으로 인해 지방세포에서 TNF-αmRNA와 단백질의 과잉생산 및 복강 내 대식세포의 활성증가 등 인슐린 수용체의 수용장애로 발생되는 인슐린 비의존형으로 구분되며, 우리나라 당뇨병 환자의 약 90% 이상이 인슐린 비의존형 당뇨병으로 알려져 있다. 당뇨병 환자의 대표적인 대사적 특징은 혈당농도 상승과 지질대사의 비정상성인데 인슐린 비의존형에서는 중성지방의 증가와 HDL-콜레스테롤의 감소로 인한 관상동맥 질환의 발생 등을 들 수 있다. In addition, diabetes mellitus of insulin receptors such as overproduction of TNF-αmRNA and protein in adipocytes and increased activity of intraperitoneal macrophages due to insulin-dependent and obesity, which increase various immune-related cytokines due to damage of β-cells in the Langerhans islet of the pancreas. It is classified as insulin-independent type caused by dysfunction of, and more than 90% of Korean diabetic patients are known as insulin-independent diabetes. Representative metabolic features of diabetics are abnormal blood glucose levels and abnormal lipid metabolism. In the insulin-independent type, the development of coronary artery disease due to an increase in triglycerides and a decrease in HDL-cholesterol.

상술한 바와 같이, 당뇨병의 치료방법은 약물치료와 식이요법이 병행되는데 술포닐우레아(sulfonyl urea), 비구아니드(biguanide) 및 트로글리타존(troglitazone) 제제 등의 약물을 장기간 복용 시 인체 면역능에 영향을 미쳐 부작용의 위험이 따르는 것으로 알려져 있어 식이요법의 역할이 매우 중요하다. 식이요법은 혈당조절, 혈청지질 수준의 정상화를 목적으로 하여 저지방식과 전분성 지수가 낮은 탄수화물을 섭취하여 식후 혈당과 혈중 인슐린 상승을 억제하는 방법을 권장하고 있는데, 대표적인 물질로는 다당류인 아카보스(acarbose)와 식이 섬유소 등이며, 최근 홍삼, 구기자, 메밀, 결명자 및 버섯 등에 함유되어 있는 생리활성 물질들이 혈당강하에 효과적이라는 연구결과가 발표되어 이에 관한 연구개발이 활 발히 진행중에 있다. 버섯류는 진균류에 속하며, 일반적으로 지질 함량은 적으나, 단백질, 당질, 무기질, 핵산 및 비타민 등의 풍부한 영양소와 독특한 맛과 향기를 함유하며, 특히, 에르고스테롤이라는 비타민 전구체가 다량 함유되어 있다. As described above, the treatment of diabetes is a combination of drug therapy and diet, which affects the immune function of the body when taking drugs such as sulfonyl urea, biguanide and troglitazone preparation for a long time. There is a known risk of side effects, so the role of diet is very important. In order to control blood sugar and normalize serum lipid levels, the diet recommends a method of suppressing post-prandial blood sugar and blood insulin elevations by ingesting low-fat diets and low starch index carbohydrates. Acarbose) and dietary fiber, and the recent research results that the biologically active substances contained in red ginseng, goji berry, buckwheat, mushrooms, mushrooms, etc. are effective in lowering blood sugar. Mushrooms belong to fungi, and generally have a low lipid content, but contain abundant nutrients such as proteins, sugars, minerals, nucleic acids, and vitamins, and unique flavors and aromas.

버섯류에서 알려지고 있는 생리활성으로는 항암, 면역증강, 콜레스테롤 및 혈당저하, 뇌졸중 및 심장병 예방과 치유, 감염 방어효과 등이 보고된 바 있으며 그 효과는 이들에 함유된 다당류에 의한 것으로 밝혀지고 있는데 그 대표적인 다당류로서는 표고버섯(Lentinus edodes)으로부터 추출된 β-1,3-글루칸, 운지버섯(Coriolus versicolor)의 배양균사체로부터 추출된 PS-K 등이 보고되고 있다. Known physiological activities in mushrooms have been reported to be anti-cancer, immune-enhancing, lowering cholesterol and blood sugar, preventing and curing stroke and heart disease, and defense against infection, and the effects are due to the polysaccharides contained in them. Representative polysaccharides include shiitake mushrooms ( Lentinus) β-1,3-glucan extracted from edodes ), PS-K extracted from culture mycelium of Coriolus versicolor , and the like have been reported.

지금까지의 버섯에 관한 주요연구로는 영양성분 분석, 인공배양 및 다당류의 추출법 등이 보고되고 있으며, 이 중 버섯의 인공배양법으로는 고체 배양법과 액체 배양법이 이용되고 있으나 전자는 노동력과 소요비용이 높아 효율성이 낮은 반면, 후자는 효율성은 높으나 기반기술이 요구되는 문제점이 지적되고 있다. Lee 등은 표고버섯 균사체 배양의 최적조건으로 온도 25℃, pH 4.0, 교반속도 300rpm, 접종량 10%, 산소통기량 1.0v/v/m을 제시하였으며(참조: Lee, B.W., et al., 'Cultural characteristics and pilot scale fermentation for the submerged mycelial culture of Lentinus edodes', Kor. J. Appl. Microbial Biotechnol., 21, 609-614, (1993)), Fraser는 양송이 균사체 배양시 효모추출물과 카제인은 균사체 증식에 매우 효과적인 영양원으로 보고하였다(참조: Fraser, I.M. 'The growth promptive effect of several amino acids on the common cultivated mushroom', Mushroom Sci., 3, 190-200, (1956)). 또한, 배양 시 균사체의 생육은 탄소원이나 질소원이외에도 비타민류, 금속이온 등 환경조건이 생육에 많은 영향을 미치는 것으로 보고되었다. Until now, the main researches on mushrooms have been reported on nutrition analysis, artificial culture and polysaccharide extraction. Among them, solid culture and liquid culture are used for artificial culture of mushrooms. High efficiency is low, while the latter is high, but the problem that the underlying technology is required. Lee et al suggested temperature 25 ℃, pH 4.0, agitation speed 300rpm, inoculum 10%, oxygen aeration 1.0v / v / m as optimal conditions for shiitake mycelium culture (Refer to Lee, BW, et al., 'Cultural characteristics and pilot scale fermentation for the submerged mycelial culture of Lentinus edodes ', Kor. J. Appl. Microbial Biotechnol., 21, 609-614, (1993)), Fraser reported that yeast extract and casein were very effective nutrient sources for mycelial growth in mushroom mycelium cultures (Fraser, IM 'The growth promptive effect of several amino acids). on the common cultivated mushroom ', Mushroom Sci., 3, 190-200, (1956)). In addition, the growth of mycelium during the cultivation has been reported that environmental conditions such as vitamins and metal ions in addition to the carbon source or nitrogen source have a significant effect on the growth.

균사체 액체배양은 다른 미생물에 비하여 생육속도가 느리고 배양 중 오염 가능성이 높기 때문에, 배양기간의 단축, 균일한 품질의 균사체 대량생산, 경제성, 유용물질의 추출 용이성 및 생리활성 물질뿐만 아니라 균사체와 배양액을 이용한 식품개발 측면까지 고려할 수 있는 배지 성분을 결정하는 것이 매우 중요하며, 균사체의 수율 증대를 위한 인삼박이나 맥주효모 추출물 등 천연소재를 이용한 연구도 있으나 아직까지 합성배지를 이용한 배양이 주류를 이루고 있으며, 천연배지에 관한 연구는 미흡한 실정이다. Since mycelium liquid culture is slower than other microorganisms and grows more likely to be contaminated during culture, it is possible to shorten the incubation period, mass production of uniform quality mycelium, economical efficiency, extractability of useful substances and bioactive substances, as well as mycelia and culture medium. It is very important to determine the media components that can be considered in terms of food development, and there are studies using natural materials such as ginseng and brewer's yeast extract to increase the yield of mycelia, but cultivation using synthetic media is still the mainstream. However, research on natural medium is insufficient.

또한, 버섯류의 다당류 추출에 관한 방법으로는 자실체를 세절한 후 일정량의 증류수를 가하여 85 내지 110℃에서 2 내지 5시간 열수 추출한 후 에탄올을 가하여 얻은 침전물을 투석하여 다당류를 수득하는 방법이 가장 보편적으로 사용되고 있다. 이외의 다당류 추출방법으로는 배양액을 분자배제량이 100,000인 한외여과장치로 24시간 농축, 2배량의 아세톤을 가해 4℃에서 24시간 방치한 후 추출하는 영지버섯으로부터 세포외 조다당류를 추출하는 방법이 있고, 배양액을 증류수로 희석한 후 NaOH를 1%(w/v) 되게 첨가하여 균체를 유리시키고 원심분리하여 얻은 상등액을 중화, 에탄올 침전하여 수득하는 Bacillus polymyxa KS-1으로부터 다당류를 추출하는 방법이 알려져 있다. Lee 등은 구름버섯의 다당류를 열수(97℃), 냉수(4℃), 메탄올(70℃), 에탄올(70℃), 아세톤(50℃), 헥산(50℃), 0.1N NaOH(60℃) 및 0.1N HCl(60℃) 등 용매별로 추출한 결과, 열수, 냉수, 0.1N HCl 및 0.1N NaOH에서 10.4 내지 18.4% 범위로 수율이 높았음을 확인하였다. In addition, as a method for extracting mushrooms of polysaccharides, a method of obtaining polysaccharides by dividing the fruiting body, adding distilled water, extracting hot water at 85 to 110 ° C. for 2 to 5 hours, and dialysising the precipitate obtained by adding ethanol to obtain polysaccharides It is used. Other methods of extracting polysaccharides include a method of extracting extracellular crude polysaccharides from Ganoderma lucidum mushrooms, which are concentrated for 24 hours in an ultrafiltration device with a molecular exclusion amount of 100,000, added with 2 times of acetone and left at 4 ° C for 24 hours. Bacillus obtained by diluting the culture solution with distilled water, adding NaOH to 1% (w / v) to free the cells and neutralizing the supernatant obtained by centrifugation and ethanol precipitation. It is known to extract polysaccharides from polymyxa KS-1. Lee et al. Used polysaccharides of cloud mushrooms in hot water (97 ℃), cold water (4 ℃), methanol (70 ℃), ethanol (70 ℃), acetone (50 ℃), hexane (50 ℃), 0.1N NaOH (60 ℃). ) And 0.1N HCl (60 ° C.), and extracted by solvent, and found that the yield was high in the range of 10.4 to 18.4% in hot water, cold water, 0.1N HCl, and 0.1N NaOH.

한편, 소나무잔나비버섯(Fomitopsis pinicola)은 우리나라의 자생버섯으로 항균성의 스테로이드를 비롯하여 기능성을 지닌 미지의 단백다당체가 함유되어 있으며 경험적으로 항당뇨 효과가 있는 것으로 알려져 있는데, 대한민국 특허공개 제 2005-60726호에 감자배지를 이용하여 배양한 소나무잔나비버섯 추출물이 포함된 혈당강하제 및 그의 제조방법이 개시되어 있으며, 최근에 본 발명자들은 상기 소나무잔나비버섯의 당뇨합병증 예방효과와 당뇨 유도성 고콜레스테롤증 개선효과(대한민국 특허출원 제 2006-1430호), 췌장세포 손상 억제효과(대한민국 특허출원 제 2006-1431호), 당뇨로 인한 활성산소 생성 억제효과(대한민국 특허출원 제 2005-133990호)를 규명한 바 있고, 활성을 나타내는 단백다당체는 β-1,3-글루칸과 β-1,6-헤테로갈락토만난이 결합되어 있는, 분자량 30만 내지 50만의 β-1,3-글루카노-β-1,6-헤테로갈락토만난에 단백질이 결합되어 있는 물질임을 밝힌 바 있다.Meanwhile, Fomitopsis pinicola ( Fomitopsis pinicola ) is a native mushroom in Korea, which contains antibacterial steroids and unknown protein polysaccharides that are functional and is known to have an antidiabetic effect. Korean Patent Publication No. 2005-60726 A hypoglycemic agent and a method for preparing the same, which include the extract of pine beetle mushrooms cultured using potato medium, have been disclosed. Recently, the present inventors have been shown to prevent the diabetic complications of the pine beetle mushroom and to improve diabetes-induced hypercholesterolemia ( Korea Patent Application No. 2006-1430), pancreatic cell damage inhibition effect (Korea Patent Application No. 2006-1431), active oxygen production inhibitory effect due to diabetes (Korean Patent Application No. 2005-133990), The protein polysaccharide exhibiting activity is the one to which β-1,3-glucan and β-1,6-heterogalactomannan are bound. It has been revealed that the protein is bound to β-1,3-glucano-β-1,6-heterogalactomannan in a weight of 300,000 to 500,000.

그러나, 종래의 배양방법으로 소나무잔나비버섯을 배양하는 데는 한계가 있었으며, 합성배지를 사용함에 따라 발생하는 위생상의 문제 및 균사체의 수율저하 등의 문제를 해결하기 위하여, 천연배지의 이용 가능성에 대하여 많은 연구가 진행중에 있다. However, there was a limit in cultivating pine beetle mushrooms by the conventional culture method, and in order to solve the problems such as hygiene problems caused by the use of synthetic medium and lowered yield of mycelia, there are many possibilities regarding the availability of natural medium. Research is ongoing.

본 발명자들은 천연배지를 위한 조성물로 녹차 및 귤피를 주목하였는데, 녹차는 소량의 유리아미노산, 카페인 및 비타민 C와 폴리페놀을 함유하고 있는 식품이며, 항산화 활성, 항암, 항염성, 혈중 콜레스테롤 저하 효과 및 고혈압 예방 등의 생리활성 기능을 나타낸다고 알려져 있으며, 귤피는 비타민 A 전구체인 β-카로 틴 및 플라보노이드와 테르펜이 풍부하게 함유되어 있어, 항산화, 노화방지, 순환계 질환의 예방, 면역력 증강 및 항암에 효과적인 것으로 알려져 있다. The present inventors noted green tea and tangerine as a composition for natural medium, green tea is a food containing a small amount of free amino acid, caffeine and vitamin C and polyphenols, antioxidant activity, anticancer, anti-inflammatory, blood cholesterol lowering effect and It is known to show physiologically active functions such as prevention of hypertension, and tangerine is rich in vitamin A precursors β-carotene and flavonoids and terpenes, which are effective for antioxidant, anti-aging, prevention of circulatory diseases, enhancement of immunity and anticancer. Known.

이에, 본 발명자들은 소나무잔나비버섯 균사체를 천연배지에 배양함으로써 합성배지를 사용함에 따라 발생하는 위생상의 문제를 해결하고 나아가 배양액을 직접 음료 등으로 활용하고자 녹차 및 귤피 추출물을 첨가한 배지에서 소나무잔나비버섯 균사체 배양의 최적 조건을 확립한 바 있으며(참조: 대한민국 특허출원 제 2005-133989호), 그 외에, 소나무잔나비버섯 자실체 및 균사체로부터 다당류를 추출하기 위한 자실체 열수 추출물, 자실체 알칼리 추출물 및 배양균사체 추출물의 제조방법을 확립한 바 있다(참조: 대한민국 특허출원 제 2006-1430호).Thus, the present inventors cultivated pine myrtle mushroom mycelium in a natural medium to solve the hygiene problems caused by using a synthetic medium and further utilize the culture medium as a beverage, such as pine green berry mushroom in a medium added with green tea and tangerine extract Optimal conditions for mycelial culture have been established (see Korean Patent Application No. 2005-133989), and besides, fruiting body hydrothermal extract, fruiting body alkali extract and cultured mycelium extract for extracting polysaccharides from pine fruit Manufacturing method has been established (see Korean Patent Application No. 2006-1430).

따라서, 소나무잔나비버섯 자실체 추출물, 천연 배지에서 배양된 균사체로부터의 추출물 및 종래의 합성 배지로부터 배양된 균사체 추출물 가운데, 가장 우수한 혈당저하 효과를 나타내는 추출물 수득 방법에 대한 연구 및 가장 우수한 혈당저하 효과를 나타내는 추출물을 포함하는 혈당강하용 조성물에 대한 연구의 필요성이 대두되고 있다. Therefore, among the pine needles fruiting fruit extract, the extract from the mycelium cultured in natural medium and the mycelium extract cultured from the conventional synthetic medium, the study on the method of obtaining an extract showing the best hypoglycemic effect and the best hypoglycemic effect There is a need for research on a blood sugar lowering composition comprising an extract.

이에, 본 발명자들은 소나무잔나비버섯 자실체 열수추출물, 일반 합성배지로 배양한 균사체 추출물, 녹차배지 또는 귤피배지로 배양한 균사체 추출물 등을 당뇨를 유발한 쥐에 식이 투여하여 혈당, 혈청지질 등을 조사한 결과, 항당뇨 효과가 증진된 최적의 추출물 조건을 확인하여, 본 발명을 완성하게 되었다. Accordingly, the present inventors have investigated the results of blood glucose, serum lipids, etc. by administering to the rats inducing diabetic rats mushrooms hot water extract, mycelium extract cultured in general synthetic medium, mycelia extract cultured in green tea medium or tangerine blood medium, etc. By confirming the optimal extract conditions, antidiabetic effect was enhanced, the present invention was completed.

결국, 본 발명의 주된 목적은 녹차 또는 귤피 배지에서 배양한, 항당뇨 효과가 증진된 소나무잔나비버섯 배양균사체 추출물을 제공하는 것이다. After all, the main object of the present invention is to provide a pine myrtle mushroom culture mycelium extract enhanced in the anti-diabetic effect, cultured in green tea or tangerine medium.

본 발명의 다른 목적은 상기 소나무잔나비버섯 배양균사체 추출물이 포함된 혈당강하용 조성물을 제공하는 것이다. It is another object of the present invention to provide a composition for lowering blood glucose, which comprises the extract of the pine myrtle cultivated mycelium.

본 발명은 녹차 또는 귤피 배지에서 배양한, 항당뇨 효과가 증진된 소나무잔나비버섯 배양균사체 추출물을 제공한다. The present invention is cultured in green tea or tangerine medium, provides a pine myrtle mushroom culture mycelium extract enhanced anti-diabetic effect.

또한, 본 발명은 상기 소나무잔나비버섯 배양균사체 추출물을 포함하는 혈당강하용 조성물을 제공한다. In addition, the present invention provides a composition for lowering blood glucose, which comprises the extract of the mycelium fungus mushroom culture mycelium.

상기 혈당강하용 조성물은 소나무잔나비버섯 배양균사체 추출물을 단독으로 포함하여도 무방하지만, 소나무잔나비버섯 자실체 열수 추출물과 혼합한 추출물을 포함하는 것이 보다 바람직하며, 배양액을 추가로 포함할 수도 있다. The blood sugar lowering composition may include pine berry butterfly mushroom culture mycelium extract alone, but more preferably comprises an extract mixed with pine berry butterfly fruit body hydrothermal extract, and may further include a culture solution.

녹차 배지 또는 귤피 배지의 제조방법은 본 발명자들의 이전 출원인 대한민국 특허출원 제 2005-133989호에 개시된 방법을 토대로 하며, 상기 출원 전체를 본 명세서에 참고로 인용한다. 녹차분말에 증류수를 가하고 냉각관을 부착하여 2 내 지 3시간 동안 가열한 후, 여과한 용액을 녹차 추출물 원액으로 하여, 이를 2.0%(v/v) 함유하는 녹차 배지를 제조한다. 또한, 건조분쇄한 귤피에 증류수를 가하고 냉각관을 부착하여 2 내지 3시간 동안 가열한 후, 여과한 용액을 귤피 추출물 원액으로 하여, 이를 2.0%(v/v) 함유하는 귤피 배지를 제조한다. The method for preparing the green tea or tangerine medium is based on the method disclosed in Korean Patent Application No. 2005-133989 to the present applicant, which is hereby incorporated by reference in its entirety. Distilled water was added to the green tea powder, and a cooling tube was attached and heated for 2 to 3 hours. Then, the filtered solution was used as the green tea extract stock solution to prepare a green tea medium containing 2.0% (v / v). In addition, distilled water was added to the dried pulverized tangerine, and a cooling tube was attached and heated for 2 to 3 hours, and then the filtered solution was used as a tangerine extract stock solution to prepare a tangerine medium containing 2.0% (v / v).

또한, 소나무잔나비버섯 자실체 열수추출물은 세절, 분쇄한 자실체에 증류수를 가하여 냉각관을 부착한 추출조를 이용하여 24시간 동안 추출한 후, 농축한 용액을 사용한다. In addition, the hot water extract of pine fruit, nasal mushroom, extracted by distilled water to the pulverized, pulverized fruiting body by using an extraction tank attached with a cooling tube for 24 hours, using a concentrated solution.

일반 배지인 감자 배지를 이용한 소나무잔나비버섯 배양균사체 추출물은 일단 균사체를 YM배지에 접종해서 계대배양한 후, 살균 및 냉각한 감자 배지(감자 열수추출물 10~20%(v/v), 설탕 1~3%(w/v), 옥수수분말 0.1~0.5%(w/v) 및 음용수 76.5~88.9%(v/v))에 접종하여 배양 및 농축한 용액을 사용한다(참조: 대한민국 특허공개 제 2005-60726호).The culture of the mycelia of pine beetle mushroom culture using the potato medium, which is a general medium, was inoculated on YM medium and subcultured, and then sterilized and cooled potato medium (potato hot water extract 10-20% (v / v), sugar 1 ~ A solution incubated and inoculated in 3% (w / v), corn powder 0.1-0.5% (w / v) and drinking water 76.5-88.9% (v / v) is used (see Korean Patent Publication No. 2005) -60726).

상기 방법으로부터 수득한 다양한 소나무잔나비버섯 추출물들의 혈당저하 효과 및 혈청지질 감소 효과 등을 하기와 같은 방법으로 조사하였다. 스트렙토조토신(streptozotocin: STZ)으로 당뇨를 유발한 쥐에 상기 추출물들이 함유된 식이사료를 4주간 투여하여 사육시킨 후, 실험쥐의 꼬리정맥으로부터 채혈하여 혈당을 분석하고, 실험쥐의 복부 대동맥으로부터 채혈하여 혈청지질을 분석하였으며, 간 및 신장을 적출하여 중량의 변화를 비교하고, 간 조직의 크산틴산화효소의 활성을 측정하였다. The hypoglycemic effect and the serum lipid reduction effect of various pine needles butterfly extracts obtained from the above method were investigated as follows. Dietary feed containing the extracts were fed to streptozotocin (STZ) -induced diabetic rats for 4 weeks, and then blood was collected from the tail vein of the mice to analyze blood glucose levels, and from the abdominal aorta of the mice. Serum lipids were analyzed by blood collection, liver and kidney were extracted to compare changes in weight, and xanthine oxidase activity of liver tissue was measured.

이하, 실시예를 통하여 본 발명을 보다 상세히 설명하고자 하지만, 본 발명의 권리범위가 이들 실시예에만 한정되는 것은 아니다. Hereinafter, the present invention will be described in more detail with reference to Examples, but the scope of the present invention is not limited only to these Examples.

실시예Example

실시예 1: 녹차 배지 및 귤피 배지를 이용한 소나무잔나비버섯 배양균사체 추출물의 제조 Example 1 : Preparation of pine myrtle mushroom culture mycelium extract using green tea medium and tangerine medium

실시예 1-1: 소나무잔나비버섯 균사체의 분리 Example 1-1 Separation of Pine Pinnacle Mushroom Mycelium

경북 포항시 소재 재생농산에서 분양받은 1년생 소나무잔나비버섯의 자실체로부터 소나무잔나비버섯 균사체를 분리하였다. 2×2×2mm의 크기로 절단한 자실체 일정량을 70%(v/v) 에탄올로 세척한 후, 감자 2.0%(w/v), 설탕 1.0%(w/v) 및 펩톤 0.6%(w/v)를 함유하는 배지에서 5.0%(w/v) 되도록 이식하여 10일간 150rpm으로 진탕배양하였다. 전기 배양으로 생성된 소나무잔나비버섯 균사체를 YM agar 배지(효모추출물 0.5%(w/v), 펩톤 0.5%(w/v), 맥아추출물 0.2%(w/v), 포도당 1.0%(v/v) 및 아가 2.0%(w/v), pH 6.5)에 접종하고, 30℃에서 5 내지 6일간 배양하여 버섯균사체를 확인한 후, 15일 간격으로 계대 배양하여 균주로 사용하였다. The mycelia of pine myrtle were isolated from the fruiting bodies of annual pine weaver butterfly which was sold from regenerated agricultural products in Pohang, Gyeongbuk. After washing a certain amount of fruiting body cut into 2 × 2 × 2 mm with 70% (v / v) ethanol, potato 2.0% (w / v), sugar 1.0% (w / v) and peptone 0.6% (w / v) was transplanted to 5.0% (w / v) in a medium containing v) and shaken at 150 rpm for 10 days. The pine myrtle mycelium produced by the electroculture was prepared in YM agar medium (yeast extract 0.5% (w / v), peptone 0.5% (w / v), malt extract 0.2% (w / v), glucose 1.0% (v / v) ) And agar was inoculated at 2.0% (w / v), pH 6.5), and cultured at 30 ° C. for 5 to 6 days to identify mushroom mycelia, and then passaged at 15-day intervals to be used as strains.

실시예 1-2: 녹차 및 귤피 배지의 제조와 소나무잔나비버섯 배양균사체 추출물의 제조 Example 1-2 Preparation of Green Tea and Tangerine Medium and Preparation of Pine Sprout Mushroom Culture Mycelia Extract

녹차 추출물을 시판되는 설록차(태평양(주))를 사용하여 귤피 추출물의 제조방법과 동일한 열수추출법으로 제조하였다. 즉, 건조분쇄(100mesh)한 녹차잎 100g에 증류수 2.5L를 가한 다음, 냉각관을 부착하여 2시간 동안 가열한 후, Miracloth(BioChem Co. USA)로 여과한 여액을 원액으로 한 녹차 추출물을 제조하였다. 또한, 대구약령시에서 구입한 귤피(진피)를 건조분쇄(100mesh)하고, 전기 건조분쇄된 귤피 100g에 증류수 2.5L를 가한 다음, 냉각관을 부착하여 2시간 동안 가열한 후, Miracloth(BioChem Co. USA)로 여과한 여액을 원액으로 한 귤피 추출물을 제조하였다. The green tea extract was prepared by the same hot water extraction method as that of the tangerine extract using commercially available Sulloc tea (Pacific). That is, 2.5L of distilled water was added to 100 g of dried green tea leaves (100mesh), and then a cooling tube was attached and heated for 2 hours, followed by preparing a green tea extract using the filtrate filtered with Miracloth (BioChem Co. USA) as a stock solution. It was. In addition, dried pulpy (dermis) purchased from Daegu Yangnyeongsi (100 mesh), 2.5L of distilled water was added to 100g of electrically dried pulverized tangerine, and then attached to a cooling tube and heated for 2 hours, followed by Miracloth (BioChem Co. USA) was prepared by extracting the tangerine extract as a stock solution.

상기 제조한 녹차 추출물 원액을 2%(v/v) 함유하는 녹차 배지(녹차 추출물 원액 2%(v/v), 포도당 5%(v/v), 효모추출물 0.5%(w/v), 펩톤 0.5%(w/v) 및 맥아추출물 0.3%(w/v), pH 5.0)와 상기 녹차 배지 조성의 2%(v/v) 녹차 추출물 원액 대신 2%(v/v) 귤피 추출물 원액을 사용한 귤피 배지를 제조하였다. Green tea medium containing 2% (v / v) of the prepared green tea extract (2% green tea extract (v / v), 5% glucose (v / v), yeast extract 0.5% (w / v), peptone 0.5% (w / v) and malt extract 0.3% (w / v), pH 5.0) and 2% (v / v) green tea extract stock solution of 2% (v / v) tangerine extract stock solution The tangerine medium was prepared.

상기 실시예 1-1에서 수득한 소나무잔나비버섯 균사체를 녹차 배지 및 귤피 배지에 접종하고, 30℃, 150 rpm 조건의 진탕 배양기에서 12일간 배양하였다. 이후, 소나무잔나비버섯 배양균사체를 포함하는 배양액을 중조(NaHCO3)로 pH 7.0으로 조정한 후 균질화하고 이를 40℃에서 1/20로 감압 농축하여 녹차 및 귤피 배지를 이용한 소나무잔나비버섯 배양균사체 추출물을 제조하였다. The pine needles mycelia obtained in Example 1-1 were inoculated in green tea medium and tangerine medium, and cultured in a shaker at 30 ° C. and 150 rpm for 12 days. Thereafter, the culture medium containing the pine myrtle mushroom culture mycelium was adjusted to pH 7.0 with sodium bicarbonate (NaHCO 3 ), homogenized and concentrated under reduced pressure to 1/20 at 40 ° C. to extract the pine myrtle mushroom culture mycelium extract using green tea and tangerine medium. Prepared.

실시예 2: 소나무잔나비버섯 자실체 열수 추출물 및 감자 배지를 이용한 배양균사체 추출물의 제조 Example 2 Preparation of Cultured Mycelium Extract Using Pine Shrimp Fruit Fruit Hot Water Extract and Potato Medium

*실시예 2-1: 소나무잔나비버섯 자실체 열수 추출물의 제조* Example 2-1 : Preparation of pine needles mushroom fruiting hot water extract

경북 포항시 소재 재생농산에서 분양받은 1년생 소나무잔나비버섯의 자실체 150g을 2×2×2cm로 세절한 후, 증류수 4L를 가하고 냉각관을 부착한 추출조를 이용하여 24시간 동안 추출한 후, 1/4로 농축하여, 3.75g/100mL의 용액을 제조하였다. After cutting 150g of fruiting body of 1 year old pine tree butterfly, which was sold from regenerated agricultural product in Pohang, Gyeongbuk, into 2 × 2 × 2cm, 4L of distilled water was added and extracted for 24 hours using an extraction tank with a cooling tube. The solution was concentrated to give a solution of 3.75 g / 100 mL.

실시예 2-2: 감자 배지를 이용한 배양균사체 추출물의 제조 Example 2-2 Preparation of Cultured Mycelia Extract Using Potato Medium

경북 포항시 소재 재생농산에서 분양받아 보존 중인 소나무잔나비버섯 균사체를 YM 배지(포도당 1%(v/v), 효모추출물 0.5%(w/v), 펩톤 0.5%(w/v) 및 맥아추출물 0.3%(w/v), pH 6.5)에 접종, 30℃에서 10일간 계대배양한 후, 121℃에서 1시간 동안 살균, 냉각한 감자 배지[(감자 열수추출물 15%(v/v), 건물양으로는 4%(w/v)), 설탕 2%(w/v), 옥수수분말 0.3%(w/v), pH 6.5]에 5%(v/v) 되도록 접종하여 30℃에서 150 rpm으로 진탕 배양기에서 12일간 배양하였다. 이후, 소나무잔나비버섯 배 양균사체를 포함하는 배양액을 중조로 pH 7.0으로 조정한 후 균질화하고, 이를 40℃에서 1/20로 감압 농축하여 배양균사체 추출물을 제조하였다. Pine myrtle mushroom mycelium, which was preserved and preserved by regenerated agricultural products in Pohang, Gyeongbuk, was prepared by YM medium (1% (glucose), yeast extract 0.5% (w / v), peptone 0.5% (w / v) and malt extract 0.3% (w / v), pH 6.5), subcultured at 30 ° C. for 10 days, sterilized and cooled at 121 ° C. for 1 hour [potato hot water extract 15% (v / v), dry weight 4% (w / v)), sugar 2% (w / v), corn powder 0.3% (w / v), pH 6.5] inoculated to 5% (v / v) and shaken at 30 rpm at 150 rpm. The incubator was incubated for 12 days. Subsequently, the culture medium containing pine myrtle cultivated mycelium was adjusted to pH 7.0 with sodium bicarbonate, homogenized, and concentrated under reduced pressure to 1/20 at 40 ° C to prepare a culture mycelium extract.

실시예 3: 각종 소나무잔나비버섯 추출물의 항당뇨 효과 비교 Example 3 Comparison of Antidiabetic Effects of Various Pine Grass Butterfly Extracts

실시예 3-1: 실험군 및 실험방법 Example 3-1 : Experimental group and experimental method

평균 체중이 225±5.2g인 Sprague-Dawley계 수컷 흰쥐를 각 실험군마다 10마리씩 총 70마리를 구입하여 실내온도 23±2℃, 습도 60±5%, 12hr 명암 사이클의 조건에서 환경에 적응시키기 위하여 일반 배합사료(Purina Co., Seoul Korea)로 1주간 예비사육한 후 실험 식이를 행하였다. To obtain a total of 70 Sprague-Dawley male rats with an average weight of 225 ± 5.2g for each experimental group, they were adapted to the environment at room temperature of 23 ± 2 ℃, humidity of 60 ± 5%, and 12hr contrast cycle. After a week of pre-breeding with a general feed (Purina Co., Seoul Korea) was carried out an experimental diet.

7개의 실험 식이군(참조: 표 1)은 다음과 같다.The seven experimental diet groups (see Table 1) are as follows.

1) NC: 정상대조군1) NC: Normal Control

2) DM: 당뇨대조군DM: Diabetic Control

3) DM-PD: 당뇨유발 후, 감자 배지(PD 배지)에서 배양한 균사체 배양 농축액(1/20) 2% 투여군3) DM-PD: 2% administration group of mycelial culture concentrate (1/20) cultured in potato medium (PD medium) after diabetes induction

4) DM-CP: 당뇨유발 후, 귤피 배지(CP 배지)에서 배양한 균사체 배양 농축액(1/20) 2% 투여군4) DM-CP: 2% administration group of mycelial culture concentrate (1/20) cultured in tangerine medium (CP medium) after diabetes induction

5) DM-GT: 당뇨유발 후, 녹차 배지(GT 배지)에서 배양한 균사체 배양 농축액(1/20) 2% 투여군5) DM-GT: 2% administration group of mycelial culture concentrate (1/20) cultured in green tea medium (GT medium) after diabetes induction

6) DM-WE: 당뇨유발 후, 자실체 열수추출물(WE) 농축액 2% 투여군6) DM-WE: fruiting body hot water extract (WE) concentrate 2% administration group after diabetes-induced

7) DM-WC: 당뇨유발 후, 자실체 열수추출물 농축액과 귤피 배지에서 배양한 배양균사체 농축액(1/20)의 1:1 혼합액 2% 투여군 7) DM-WC: 1% mixture of 1% mixed solution of fruiting body hot water extract concentrate and cultured mycelium concentrate (1/20) cultured in K.

표 1: 동물실험을 위한 기본식이조성(g/kg) Table 1 : Basic Dietary Composition for Animal Experiments (g / kg)

식이조성Diet NCNC DMDM DM-PDDM-PD DM-CPDM-CP DM-GTDM-GT DM-WEDM-WE DM-WCDM-WC 카제인Casein 200200 200200 195195 200200 195195 200200 195195 콘스타치cornstarch 150150 150150 142.5142.5 150150 142.5142.5 150150 142.5142.5 설탕Sugar 500500 500500 500500 500500 500500 500500 500500 셀룰로즈Cellulose 5050 5050 4545 49.549.5 4545 49.549.5 4545 콘오일Corn oil 5050 5050 4848 5050 4848 5050 4848 AIN-미네랄믹스쳐1 ) AIN-mineral mix 1 ) 3535 3535 34.534.5 3535 34.534.5 3535 34.534.5 AIN-비타민믹스쳐2 ) AIN-Vitamin Mixture 2 ) 1010 1010 1010 1010 1010 1010 1010 DL-메티오닌DL-Methionine 33 33 33 33 33 33 33 콜린바이타타레이트Cholinevitatarate 22 22 22 22 22 22 22 균사체 PD배양액(1/20 농축)Mycelia PD culture solution (1/20 concentration) -- -- 2020 -- -- -- -- 균사체 CP배양액(1/20 농축)Mycelia CP culture solution (1/20 concentration) -- -- -- 2020 -- -- 1010 균사체 GT배양액(1/20 농축)Mycelia GT culture (1/20 concentration) -- -- -- -- 2020 -- -- 자실체 열수추출물(3.75g/100mL)Fruiting body hot water extract (3.75g / 100mL) -- -- -- -- -- 2020 -- 자실체 열수추출물+균사체 CP배양액(1:1)Fruiting body hot water extract + mycelium CP culture solution (1: 1) -- -- -- -- -- -- 1010 총합    total 1,0001,000 1,0001,000 1,0001,000 1,0001,000 1,0001,000 1,0001,000 1,0001,000

1)AIN-미네랄믹스쳐(g/kg): 젖산칼슘 620.0, 염화나트륨 74.0, 제2인산칼륨 220.0, 황산칼륨 52.0, 산화마그네슘 23.0, 아망간산카보네이트 3.3, 구연산철 6.0, 탄산아연 1.0, 탄산구리 0.2, 요오드산칼륨 0.01, 소듐셀레나이트 0.01 및 황산크롬칼륨 0.5를 미세한 분말로 하여 1,000g 제조 1) AIN-mineral mixture (g / kg): calcium lactate 620.0, sodium chloride 74.0, potassium diphosphate 220.0, potassium sulfate 52.0, magnesium oxide 23.0, manganese carbonate 3.3, iron citrate 6.0, zinc carbonate 1.0, copper carbonate 0.2 , 1,000 g of potassium iodide 0.01, sodium selenite 0.01 and potassium chromium sulfate 0.5 as fine powder

2)AIN-비타민믹스쳐(mg/kg): 염산티아민 600, 리보플라빈 600, 염산피리독신 700, 니코틴산 3,000, D-판토텐산칼슘 1,600, 엽산 200, D-비오틴 20, 비타민 B12 2.5, 비타민 A 400,000 IU, 비타민 D3 100,000 IU, 비타민 E 7,500 IU 및 비타민 K 75를 미세한 분말로 하여 1,000g 제조 2) AIN-vitamin mixture (mg / kg): Thiamine hydrochloride 600, Riboflavin 600, Pyridoxine hydrochloride 700, Nicotinic acid 3,000, D-calcium pantothenate 1,600, Folic acid 200, D-biotin 20, Vitamin B12 2.5, Vitamin A 400,000 IU, 1,000 g of Vitamin D3 100,000 IU, Vitamin E 7,500 IU and Vitamin K 75 as fine powder

실시예 3-2: 항당뇨 효과 측정 Example 3-2 : Antidiabetic Effect Measurement

체중증가량, 식이 섭취량 및 Weight gain, dietary intake, 식이효율Dietary efficiency

스트렙토조토신(STZ, Sigma Chem. Co. MO, USA)을 0.1M 시트르산 완충액(pH 4.3)에 용해시켜 체중 250g 당 40mg/kg 농도로 대퇴부 근육에 주사하였으며, STZ 투여 48시간 후에 공복 시 꼬리정맥으로부터 취한 혈액의 혈당농도가 200mg/㎗ 이상일 경우에 당뇨로 간주하였다.Streptozotocin (STZ, Sigma Chem. Co. MO, USA) was dissolved in 0.1M citric acid buffer (pH 4.3) and injected into the femoral muscle at a concentration of 40 mg / kg per 250 g of body weight. Fasting tail vein at 48 hours after STZ administration Diabetes was considered when the blood glucose concentration from the blood was 200 mg / dl or more.

혈당분석은 Gluco-Tester(Life Scan lnc., USA)를 사용하여 매일 오전 10~12시에 측정하였으며, 공복 시의 꼬리부위 혈관에서 란셋으로 채혈하였다. Blood glucose analysis was measured at 10 to 12 am daily using Gluco-Tester (Life Scan Lnc., USA), and blood was collected from the vessels of the fasting tail with lancet.

체중, 식이 및 음용수 섭취량은 전 실험 기간을 통하여 매일 일정한 시간에 측정하였고, 식이효율(food efficiency ratio, FER)은 같은 기간 동안의 체중증가량을 동일 기간의 식이 섭취량으로 나눈 값으로 하였으며, 체중증가량, 식이섭취량 및 식이효율을 하기 표 2에 나타내었다. Body weight, diet and drinking water intake were measured at regular times every day throughout the entire experimental period, and food efficiency ratio (FER) was the weight gain for the same period divided by the intake of the same period. Dietary intake and dietary efficiency are shown in Table 2 below.

당뇨 유발군(DM)에서는 정상군(NC)에 비하여 유의적으로 체중이 감소하였고(58% 감소), 식이섭취량은 14% 증가, 물 섭취량은 84% 증가, 뇨 배설량은 108%가 증가하여 당뇨로 인한 3다 현상과 체중감소 현상이 나타났다. 나머지 식이투여군에서도 상기 3다 현상과 체중감소 현상이 나타났으나, DM군에 비하여 그 증상이 크게 완화되어 항당뇨 효과를 보였는데, 그 중에서, DM-WC군과 DM-GT군에서 항당뇨 효과가 높았으며, 종래 사용되고 있는 배지인 감자 배지에 비하여 현저한 차이를 나타내었다. 즉, 체중감소율은 DM-GT군, DM-CP군, DM-PD군, DM-WE군 및 DM-WC군에서 각각 17%, 16%, 32%, 23% 및 15%로 녹차 및 귤피 배지에서 배양한 배양액과 자실체 열수추출물과 귤피 배지에서 배양한 배양액의 혼합액이 감자 배지에서 배양한 배양액에 비하여 효과가 약 2배로 컸다. 기타 식이섭취량, 식이효율, 물 섭취량 및 뇨 배설량에 있어서도 DM-CP군과 DM-WC군을 식이투여한 그룹에서 가장 효과가 컸음을 알 수 있었다(참조: 표 2).In the diabetes-induced group (DM), body weight was significantly reduced (58% decrease) compared to the normal group (NC), dietary intake increased by 14%, water intake increased by 84%, and urinary excretion increased by 108%. Because of this, the phenomenon of triad and weight loss occurred. In the other diet-administered groups, the above-described trivalent phenomenon and weight loss were observed, but the symptoms were alleviated significantly compared to the DM group, showing anti-diabetic effect. Among them, the anti-diabetic effect in the DM-WC and DM-GT groups Was high and showed a significant difference compared to the potato medium which is a conventionally used medium. That is, the weight loss rate was 17%, 16%, 32%, 23% and 15% in DM-GT group, DM-CP group, DM-PD group, DM-WE group and DM-WC group, respectively. The mixed solution of the culture medium, the fruiting body hot water extract and the culture medium cultured in the tangerine medium was about twice as effective as the culture medium grown in the potato medium. Other dietary intakes, dietary efficiency, water intake, and urine excretion were the most effective in the DM-CP and DM-WC groups (Table 2).

표 2: STZ로 당뇨유발한 쥐의 증체량, 식이섭취량, 식이효율, 물섭취량 및 뇨배설량에 미치는 각종 소나무잔나비버섯 추출물이 함유된 식이의 4주간 급여 효과 Table 2 : Dietary Effect of Four-Week Diets Containing Various Extracts of Pine Needles on the Weight Gain, Dietary Intake, Dietary Efficiency, Water Intake, and Urinary Excretion in STZ-Induced Diabetic Rats

그룹1 ) Group 1 ) 최종체중 (g)Final weight (g) 증체량 (g/week)Weight gain (g / week) 식이섭취량 (g/week)Dietary Intake (g / week) 식이효율2 ) Dietary Efficiency 2 ) 물섭취량 (mL/week)Water intake (mL / week) 뇨배설량 (mL/day) Urine excretion (mL / day) NC NC 371.2±11.2371.2 ± 11.2 36.5±5.336.5 ± 5.3 176.5±6.1176.5 ± 6.1 0.21±0.040.21 ± 0.04 231.0±16.1231.0 ± 16.1 74.1±16.074.1 ± 16.0 DM DM 213.4±10.3213.4 ± 10.3 -2.9±0.9-2.9 ± 0.9 201.7±8.9201.7 ± 8.9 -0.14±0.01-0.14 ± 0.01 424.3±31.7424.3 ± 31.7 154.4±25.6154.4 ± 25.6 DM-PD DM-PD 250.6 ±6.4250.6 ± 6.4 6.3±4.56.3 ± 4.5 187.4±5.1187.4 ± 5.1 0.03±0.030.03 ± 0.03 345.6±25.2345.6 ± 25.2 124.7±12.4124.7 ± 12.4 DM-CP DM-CP 312.7 ±7.6312.7 ± 7.6 21.8±5.721.8 ± 5.7 180.9±4.7180.9 ± 4.7 0.12±0.040.12 ± 0.04 298.3±20.4298.3 ± 20.4 82.7±13.882.7 ± 13.8 DM-GT DM-GT 307.0 ±7.5307.0 ± 7.5 20.5±6.420.5 ± 6.4 182.0±6.7182.0 ± 6.7 0.11±0.040.11 ± 0.04 326.4±29.5326.4 ± 29.5 99.6 ±7.599.6 ± 7.5 DM-WE DM-WE 286.5 ±8.4286.5 ± 8.4 15.4±6.215.4 ± 6.2 185.6±6.9185.6 ± 6.9 0.08±0.040.08 ± 0.04 320.0±30.8320.0 ± 30.8 110.7±7.5110.7 ± 7.5 DM-WC DM-WC 314.3 ±5.7314.3 ± 5.7 22.1±4.422.1 ± 4.4 179.8±5.4179.8 ± 5.4 0.12±0.030.12 ± 0.03 296.2±21.3296.2 ± 21.3 81.9±14.181.9 ± 14.1

1): NC: 정상대조군, DM: 당뇨대조군, DM-PD: 당뇨유발 후, 감자 배지(PD 배지)에서 배양한 균사체 배양 농축액(1/20) 2% 투여군, DM-CP: 당뇨유발 후, 귤피 배지(CP 배지)에서 배양한 균사체 배양 농축액(1/20) 2% 투여군, DM-GT: 당뇨유발 후, 녹차 배지(GT 배지)에서 배양한 균사체 배양 농축액(1/20) 2% 투여군, DM-WE: 당뇨유발 후, 자실체 열수추출물(WE) 농축액 2% 투여군, DM-WC: 당뇨유발 후, 자실체 열수추출물 농축액과 귤피 배지에서 배양한 배양균사체 농축액(1/20)의 1:1 혼합액 2% 투여군 1) : NC: normal control group, DM: diabetes control group, DM-PD: after diabetes induction, mycelium culture concentrate (1/20) 2% administration group cultured in potato medium (PD medium), DM-CP: after diabetes induction, 2% administration group of mycelial culture concentrate (1/20) cultured in tangerine medium (CP medium), DM-GT: 2% administration of mycelial culture concentrate (1/20) cultured in green tea medium (GT medium) after diabetes induction, DM-WE: 2% administration of fruiting body hot water extract (WE) concentrate after induction of diabetes mellitus, DM-WC: 1: 1 mixture of cultured mycelium concentrate (1/20) cultured in fruiting body hot water extract concentrate and gulpie medium after diabetes induction 2% administration group

2) : 식이효율: 전 체중증가량/ 전 식이 섭취량 2) : Dietary efficiency: total weight gain / total dietary intake

장기 중량Long-term weight

당뇨병에 걸리면 체내 인슐린 저하와 그 저항성으로 인한 비정상적인 당대사 로 아세틸-CoA에서 지질대사 체계가 형성되어 간장 내에 지질성분이 축적되는 것으로 알려져 있으며, 특히, 스트렙토조토신으로 유발한 당뇨쥐에 있어서는 탄수화물 대사에 관여하는 간장 내 글루코스-6-포스파타제의 활성이 증가하여 간장이 배대해 진다. 또한, 당뇨병에 걸리면 신장도 비대해 지는데 이는 당뇨로 인하여 농도가 높아진 혈장 포도당이 글리코겐 등으로 대사되어 사구체 내의 혈관간세포(mesangial cell)에 축적되기 때문이다. Diabetes is known to be a metabolic system of acetyl-CoA due to abnormal insulin metabolism due to lowering insulin and resistance of the body, and lipid components are accumulated in the liver, especially carbohydrate metabolism in streptozotocin-induced diabetic rats Increasing the activity of glucose-6-phosphatase in the liver, which is involved in the liver, doubles the liver. In addition, diabetes mellitus increases the kidneys because the concentration of plasma glucose due to diabetes is metabolized by glycogen and accumulate in the blood vessels (mesangial cells) in the glomeruli.

당뇨유발 후 4주간 사육한 흰쥐의 간장 및 신장의 중량의 변화를 비교해 본 결과, DM군 간장의 체중대비 중량%는 NC군에 비하여 48% 증가하여 당뇨로 인한 간의 비대증상이 확인되었으며, 실험식이군에서는 DM군에 비해서는 당뇨로 인한 간장 비대증상을 완화시켰다. DM-CP군과 DM-WC군에서 이러한 완화효과가 가장 컸으며, 신장의 경우도 간장과 동일한 경향을 나타내었다(참조: 표 3).Of rats bred for 4 weeks after diabetes As a result of comparing the changes in weight of liver and kidney, the weight percent of DM in the DM group increased by 48% compared to the NC group, and the hypertrophy of liver due to diabetes was confirmed. Hypertrophy was alleviated. In the DM-CP group and DM-WC group, the alleviating effect was greatest, and the kidney showed the same tendency as the liver (see Table 3).

표 3: 당뇨유발 후 4주 동안 각종 소나무잔나비버섯 추출물이 함유된 식이 급여가 간장 및 신장 중량(체중대비 %)에 미치는 영향 Table 3 : Effect of Dietary Supplements Containing Various Pine Sprout Mushroom Extracts on Soy and Kidney Weight (% of Weight) for 4 Weeks after Diabetes Induction

실험군1 ) Experimental group 1 ) 간장중량Soy weight 간장중량Soy weight NC NC 2.47±0.04d 2.47 ± 0.04 d 0.64±0.07a 0.64 ± 0.07 a DM DM 3.65±0.16a 3.65 ± 0.16 a 0.83±0.12a 0.83 ± 0.12 a DM-PD DM-PD 3.08±0.09b 3.08 ± 0.09 b 0.74±0.06a 0.74 ± 0.06 a DM-CP DM-CP 2.60±0.12cd 2.60 ± 0.12 cd 0.65±0.07a 0.65 ± 0.07 a DM-GT DM-GT 2.83±0.17bC 2.83 ± 0.17 bC 0.66±0.08a 0.66 ± 0.08 a DM-WE DM-WE 2.92±0.18b 2.92 ± 0.18 b 0.73±0.07a 0.73 ± 0.07 a DM-WC DM-WC 2.59±0.11cd 2.59 ± 0.11 cd 0.64±0.06a 0.64 ± 0.06 a

*1) 표 2에서와 동일* 1) Same as in Table 2

2) 각 실험군 당 10마리의 값을 평균±표준편차로 나타낸 것이고, 서로 다른 문자는 5% 이내에서 유의성이 있음을 나타냄. 2) The values of 10 animals in each experimental group are expressed as mean ± standard deviation, and different characters are significant within 5%.

혈당 함량Blood sugar content

당뇨를 유발시킨 쥐에 실험식이를 4주간 급여하는 동안 혈당의 변화를 조사하였다. 그 결과, DM군은 4주간의 실험식이 동안 523.5~546.5 mg/dL을 유지하였다. 그러나, 실험 식이군에서는 정도의 차이는 있으나 혈당의 감소를 보였으며, 급여 4주째의 혈당 감소율은 DM-GT군이 69%, DM-CP군이 74%, DM-PD군이 53%, DM-WE군이 58%, DM-WC군이 75%로 나타났다. 이러한 결과는 균사체의 배양조건에 따라 그 효능에 차이를 나타낸 결과로 기존의 감자배지에 비하여 귤피나 녹차배지 또는 여기에 자실체 열수추출물을 혼합한 경우에 높은 효과가 있음을 알 수 있었다(참조: 표 4). 특히, 종래의 감자 배지를 이용하여 배양한 배양균사체 추출물 경우의 4주 후 개선효과를 살펴보면, 투여 전과 후에 혈당이 약 292 mg/dl 저하하여 약 53%의 개선효과를 보이고 있는 반면, 귤피 배지를 이용하여 배양한 배양균사체 추출물 경우는 투여 전과 후에 혈당이 약 406 mg/dl 저하하여 약 74%의 혈당 개선효과를 보이고 있다. Diabetes-induced rats were examined for changes in blood glucose during the four-week diet. As a result, DM group maintained 523.5 ~ 546.5 mg / dL during the four weeks diet. However, in the experimental diet group, there was a difference in the degree of blood glucose, and the blood glucose reduction rate at the 4th week of feeding was 69% in the DM-GT group, 74% in the DM-CP group, 53% in the DM-PD group, and DM. 58% of the WE groups and 75% of the DM-WC groups. These results showed a difference in efficacy according to the culture conditions of the mycelium. As a result, it was found that there was a high effect when the mixture of citrus fruit or green tea medium or fruiting body hot water extract was compared to the conventional potato medium (see Table: 4). In particular, the improvement effect after 4 weeks in the case of the culture mycelium extract cultured using the conventional potato medium, the blood sugar was reduced by about 292 mg / dl before and after administration showed an improvement effect of about 53%, In the case of cultured mycelium extracts, the blood glucose was decreased by about 406 mg / dl before and after administration, which showed about 74% improvement in blood glucose.

표 4: 당뇨유발 후 4주간 소나무잔나비버섯 추출물이 함유된 실험식이를 급여하는 동안 쥐의 혈당변화 비교 Table 4 : Comparison of Blood Glucose Changes in Rats During Dietary Diet Containing Pineapple Butterfly Extract for 4 Weeks After Diabetic Induction

그 룹1 ) Group 1 ) 식이기간 (주)Dietary period (Note) 1          One 22 33 44 NC NC 117.6±12.3bA ,2) 117.6 ± 12.3 bA , 2) 124.3±11.3cA 124.3 ± 11.3 cA 118.5± 7.3dA 118.5 ± 7.3 dA 120.6±12.4dA 120.6 ± 12.4 dA DM DM 546.5±24.5aA 546.5 ± 24.5 aA 550.4±32.3aA 550.4 ± 32.3 aA 549.6±32.4aA 549.6 ± 32.4 aA 523.5±32.8aA 523.5 ± 32.8 aA DM-PD  DM-PD 538.7±19.6aA 538.7 ± 19.6 aA 525.3±35.6aA 525.3 ± 35.6 aA 435.5±36.1bB 435.5 ± 36.1 bB 254.6±22.5bC 254.6 ± 22.5 bC DM-CP  DM-CP 532.4±20.8aA 532.4 ± 20.8 aA 453.9±30.8bB 453.9 ± 30.8 bB 344.2±37.6cC 344.2 ± 37.6 cC 140.2±27.1cdD 140.2 ± 27.1 cdD DM-GT  DM-GT 528.7±28.7aA 528.7 ± 28.7 aA 549.8±56.2aA 549.8 ± 56.2 aA 347.4±51.2cB 347.4 ± 51.2 cB 165.4±19.7cC 165.4 ± 19.7 cC DM-WE  DM-WE 540.5±21.4aA 540.5 ± 21.4 aA 500.7±32.3abA 500.7 ± 32.3 abA 382.7±35.4bcB 382.7 ± 35.4 bcB 224.5±23.5bC 224.5 ± 23.5 bC DM-WC DM-WC 535.3±21.2aA 535.3 ± 21.2 aA 456.5±31.4bB 456.5 ± 31.4 bB 345.8±338.3cC 345.8 ± 338.3 cC 135.8±25.6cdD 135.8 ± 25.6 cdD

1) 표 2에서와 동일 1) Same as in Table 2

2) 각 실험군 당 10마리의 값을 평균±표준편차로 나타낸 것이고, 서로 다른 문자는 5% 이내에서 유의성이 있음을 나타냄. 2) The values of 10 animals in each experimental group are expressed as mean ± standard deviation, and different characters are significant within 5%.

실시예 4: 소나무잔나비버섯 추출물이 함유된 실험식이로 인한 혈청지질 개선 및 간조직의 크산틴산화효소 억제효과 Example 4 Improvement of Serum Lipids and Inhibitory Effect of Xanthine Oxidase on Liver Tissues from Experimental Diet Containing Pineapple Butterfly Extract

실험군 및 실험방법은 실시예 3과 동일하게 실시하였으며, 실험식이로 4주간 사육한 흰쥐를 물 이외는 주지 않으며 24시간 동안 절식시키고, 에틸에테르로 마취하여 개복한 후, 복부 대동맥으로부터 채혈한 다음, 빙냉의 생리식염수로 간장을 관류하고 장기를 적출하였다. 채취한 혈액은 냉장온도에 7시간 방치한 후, 3,000 rpm에서 10분간 원심분리하여 혈청을 분리하였으며, 적출한 간의 일정량에 4배량의 빙냉의 0.25M 슈크로즈 용액을 가하여 마쇄 균질화한 다음 1,000×g에서 10분간 원심분리한 후, 상등액을 다시 10,000×g에서 30분간 원심분리하여 분리된 상등액을 cytosol 분획으로 하였다. 모든 분석시료는 -70℃ deep freezer에 보관하고, 실험시 꺼내어 사용하였다. Experimental group and experimental method was carried out in the same manner as in Example 3, the rats were fed for 4 weeks as an experimental diet, except water, fasted for 24 hours, anesthetized with ethyl ether, and opened, after which blood was collected from the abdominal aorta, The liver was perfused with ice-cold saline and the organs were extracted. The collected blood was left at refrigeration temperature for 7 hours, and then serum was separated by centrifugation at 3,000 rpm for 10 minutes, and homogenized by grinding with 4 times of ice-cold 0.25M sucrose solution in a predetermined amount of liver. After centrifugation for 10 minutes at, the supernatant was further centrifuged at 10,000 × g for 30 minutes to separate the supernatant as a cytosol fraction. All samples were stored in -70 ℃ deep freezer, was taken out of the experiment.

혈청지질의Serum lipid 분석 analysis

혈청중성지질, 총콜레스테롤, HDL-콜레스테롤 함량은 kit 시약(AM 157S-K, AM 202-K, AM 203-K, Asanpharm Co., Korea)으로 측정하였다. 즉, 중성지질의 함량은 혈청 0.02㎖ 에 효소용액 3.0㎖씩을 가하여 37℃에서 10분간 반응시킨 후 550nm에서 흡광도를 측정하였다. 혈청 총콜레스테롤 함량은 중성지질의 경우와 동일한 용량비로 37℃에서 5분간 반응, 500nm에서 흡광도를 측정하여 계산식(mg/dL = (표준용액의 흡광도/검액의 흡광도)×300)에 의하여 함량을 구하였다. 또한, HDL-콜레스테롤 함량은 혈청 0.1㎖에 효소용액 3.0㎖을 가하여 37℃에서 5분간 반응시킨 후 500nm에서 흡광도를 측정, 계산식(mg/dL = (표준용액의 흡광도/검체용액의 흡광도)×100)에 의하여 함량을 산출하였다. LDL-콜레스테롤 함량은 총콜레스테롤-(HDL-콜레스테롤량)-(중성지질/5)로 계산하였다.Serum neutral lipid, total cholesterol, HDL-cholesterol content was measured by kit reagent (AM 157S-K, AM 202-K, AM 203-K, Asanpharm Co., Korea). That is, the content of neutral lipid was added to each of 0.02 ml of serum and 3.0 ml of enzyme solution and reacted at 37 ° C. for 10 minutes, and the absorbance was measured at 550 nm. The serum total cholesterol content was obtained by the reaction formula (mg / dL = (absorbance of standard solution / absorbance of sample solution) × 300) by measuring absorbance at 500 nm for 5 minutes at 37 ° C at the same dose ratio as that of neutral lipid. . In addition, the HDL-cholesterol content was measured by adding 3.0 ml of enzyme solution to 0.1 ml of serum and reacting at 37 ° C. for 5 minutes, and then measuring the absorbance at 500 nm. The content was calculated by LDL-cholesterol content was calculated as total cholesterol- (HDL-cholesterol content)-(neutral lipid / 5).

혈청 중성지질의 함량은 DM군에서는 정상군인 NC군에 비하여 73%가 증가한 반면 DM-GT군은 16%, DM-CP군은 8%, DM-PD군은 47%, DM-WE군은 39%, DM-WC는 7%의 증가로 DM-WC군과 DM-CP군이 비슷한 수준으로 증가율이 가장 낮았다. 총 콜레스테 롤의 평균함량은 중성지질의 경우와 동일한 경향을 보였으나 유의차는 없었다. HDL-콜레스테롤 함량은 DM군이 NC군보다 19%가 낮았으나 실험 식이군에서는 정상군인 NC군과 유의차를 보이지 않았다. LDL-콜레스테롤 함량은 DM군에서는 정상군에 비하여 42%가 높았으나 DM-WC군, DM-CP군 및 DM-GT군은 정상군과 거의 차이가 없거나 오히려 낮아 DM-PD군에 비하여 혈청지질을 개선시키는 효과가 더욱 높았다(참조: 표 5). Serum triglyceride content increased by 73% in the DM group compared to the NC group, which was normal, compared with 16% in the DM-GT group, 8% in the DM-CP group, 47% in the DM-PD group, and 39% in the DM-WE group. In addition, DM-WC increased by 7%, with the DM-WC group and DM-CP group having the same level of increase. The average content of total cholesterol was the same as that of neutral lipid, but there was no significant difference. The HDL-cholesterol content was 19% lower in the DM group than in the NC group, but there was no significant difference in the experimental group in the NC group. The LDL-cholesterol content was 42% higher in the DM group than in the normal group, but the DM-WC, DM-CP, and DM-GT groups showed little or no difference from the normal group. The effect of improving was even higher (see Table 5).

표 5: 당뇨유발 후 4주 동안 소나무잔나비버섯 추출물이 함유된 식이 투여가 혈청지질에 미치는 영향 Table 5 : Effect of Dietary Containing Pineapple Butterfly Extract on Serum Lipids During 4 Weeks after Diabetic Induction

그룹1 ) Group 1 ) 중성지질 (mg/dL)Neutral Lipids (mg / dL) 총콜레스테롤 (mg/dL)Total Cholesterol (mg / dL) HDL-콜레스테롤 (mg/dL)HDL-cholesterol (mg / dL) LDL-콜레스테롤 (mg/dL)2) LDL-cholesterol (mg / dL) 2) NC NC 72.4±13.5c 72.4 ± 13.5 c 121.5±12.4a,3) 121.5 ± 12.4 a, 3) 56.5±5.9a 56.5 ± 5.9 a 50.5±5.6bc 50.5 ± 5.6 bc DM DM 125.6±13.4a 125.6 ± 13.4 a 142.5±17.5a 142.5 ± 17.5 a 45.8±4.7b 45.8 ± 4.7 b 71.6±6.4a 71.6 ± 6.4 a DM-PD DM-PD 106.3±12.0ab 106.3 ± 12.0 ab 134.6±10.3a 134.6 ± 10.3 a 49.0±2.4ab 49.0 ± 2.4 ab 64.3±5.3a 64.3 ± 5.3 a DM-CP DM-CP 78.2±11.5c 78.2 ± 11.5 c 112.4±13.3a 112.4 ± 13.3 a 53.5±4.5ab 53.5 ± 4.5 ab 43.3±4.7c 43.3 ± 4.7 c DM-GT DM-GT 84.3±10.8bc 84.3 ± 10.8 bc 120.7±12.4a 120.7 ± 12.4 a 52.3±3.3ab 52.3 ± 3.3 ab 51.5±5.6bc 51.5 ± 5.6 bc DM-WE DM-WE 100.3±12.5abc 100.3 ± 12.5 abc 130.5±12.4a 130.5 ± 12.4 a 50.3±3.1ab 50.3 ± 3.1 ab 60.1±6.4ab 60.1 ± 6.4 ab DM-WC DM-WC 77.8±10.3c 77.8 ± 10.3 c 112.4±13.3a 112.4 ± 13.3 a 53.5±4.5ab 53.5 ± 4.5 ab 43.3±3.9c 43.3 ± 3.9 c

1) 표 2에서와 동일. 1) Same as in Table 2.

2)총콜레스테롤 ― (HDL-콜레스테롤량+중성지질/5). 2) Total Cholesterol-(HDL-Cholesterol Amount + Neutral Lipid / 5).

3)실험동물 10마리의 평균치와 표준편차를 나타냄. 종축의 서로 다른 문자(a-c)는 5% 이내에서 유의성이 있음을 나타냄. 3) The mean and standard deviation of 10 experimental animals. Different letters on the vertical axis (ac) indicate significance within 5%.

간 조직의 Liver tissue 크산틴산화효소Xanthine oxidase 활성 activation

간조직의 크산틴산화효소(xanthine oxidase:XOD)의 활성도 측정은 크산틴을 기질로 하여 30℃에서 10분간 반응시켜 생성된 요산을 292nm에서 흡광도를 측정하는 Stirpe 등의 방법에 준하여 측정하였다. 효소의 활성 단위는 간 조직 단백질 1mg이 1분 동안 반응하여 기질로부터 생성시킨 요산의 양을 nmol 농도로 표시하였다.The activity of xanthine oxidase (XOD) in liver tissue was measured according to the method of Stirpe et al., Which measured absorbance at 292 nm for uric acid produced by reacting xanthine as a substrate for 10 minutes at 30 ° C. In the active unit of the enzyme, 1 mg of liver tissue protein was reacted for 1 minute, and the amount of uric acid generated from the substrate was expressed in nmol concentration.

크산틴산화효소는 간의 손상 시에 그 활성이 증가하며, 에탄올, 사염화탄소, 스트렙토조토신 등의 독성물질의 투여 시에 크산틴의 산화가 증가되어 활성이 증가하는 것으로 보고되어 있으며, O type의 활성도와 O/T ratio(%)가 높으면 활성산소 종의 생성이 촉진됨을 나타낸다. It has been reported that xanthine oxidase increases its activity when it damages the liver, and its activity increases due to increased oxidation of xanthine upon administration of toxic substances such as ethanol, carbon tetrachloride and streptozotocin. Higher O and T ratios (%) indicate the production of reactive oxygen species.

하기 표 6은 당뇨를 유발한 쥐에 4주간의 실험식이를 급여하였을 때의 크산틴산화효소의 활성도를 비교한 것이다. 그 결과, 총 크산틴산화효소의 활성은 유의적인 차이를 보이지 않았으나, O type 활성과 O/T(%)는 DM-PD군에 비하여 DM-CP군과 DM-WC 및 DM-GT군이 현저하게 낮았을 뿐만 아니라 정상군과 대등하여 당뇨에 의하여 생성되는 활성산소종의 생성을 크게 억제하는 효과를 나타냄을 알 수 있었다.Table 6 below compares the activity of xanthine oxidase when diabetic rats were fed an experimental diet for 4 weeks. As a result, there was no significant difference in the total xanthine oxidase activity, but O type activity and O / T (%) were significantly higher in DM-CP group, DM-WC and DM-GT group than DM-PD group. Not only was it low, it was found to have an effect of significantly inhibiting the production of reactive oxygen species produced by diabetes in parallel with the normal group.

표 6: 당뇨유발 후 4주간 실험식이를 급여한 쥐 간조직의 크산틴산화효소 활성 비교 Table 6 : Comparison of xanthine oxidase activity of rat liver tissue fed experimental diet for 4 weeks after diabetes induction

그 룹1 ) Group 1 ) Total Total O typeO type O/T(%)O / T (%) NC NC 4.61±0.19a,2) 4.61 ± 0.19 a, 2) 1.10±0.39d 1.10 ± 0.39 d 23.86±7.18d 23.86 ± 7.18 d DM DM 4.30±0.27a 4.30 ± 0.27 a 3.15±0.54a 3.15 ± 0.54 a 73.26±7.48a 73.26 ± 7.48 a DM-PD DM-PD 4.48±0.12a 4.48 ± 0.12 a 2.40±0.20b 2.40 ± 0.20 b 53.57±5.74b 53.57 ± 5.74 b DM-CP DM-CP 4.60±0.13a 4.60 ± 0.13 a 1.16±0.39d 1.16 ± 0.39 d 25.22±8.94d 25.22 ± 8.94 d DM-GT DM-GT 4.56±0.18a 4.56 ± 0.18 a 1.35±0.34cd 1.35 ± 0.34 cd 29.61±8.30cd 29.61 ± 8.30 cd DM-WE DM-WE 4.52±0.14a 4.52 ± 0.14 a 1.97±0.32bc 1.97 ± 0.32 bc 43.58±8.17bc 43.58 ± 8.17 bc DM-WC DM-WC 4.60±0.12a 4.60 ± 0.12 a 1.18±0.32d 1.18 ± 0.32 d 25.65±8.51d 25.65 ± 8.51 d

1) 표 2에서와 동일. 1) Same as in Table 2.

2) 실험동물 10마리의 평균치와 표준편차를 나타냄. 종축의 서로 다른 문자(a-c)는 5% 이내에서 유의성이 있음을 나타냄. 2) The mean and standard deviation of 10 experimental animals. Different letters on the vertical axis (ac) indicate significance within 5%.

이상에서 상세히 설명하고 입증하였듯이, 본 발명은 녹차 또는 귤피추출물을 함유한 배지에서 배양한, 항당뇨 효과가 증진된 소나무잔나비버섯 배양균사체 추출물에 관한 것이다. 본 발명의 소나무잔나비버섯 배양균사체 추출물을 이용하면, 종래의 감자 배지를 사용하여 배양한 배양균사체 추출물의 혈당저하 효과보다 현저히 큰 효과를 나타낼 수 있어서, 당뇨환자를 위한 기능성 식품에 널리 활용될 수 있을 것이다. As described and demonstrated in detail above, the present invention relates to a pine myrtle mushroom culture mycelium extract with enhanced anti-diabetic effect, cultured in a medium containing green tea or tangerine extract. By using the pine myrtle mushroom culture mycelium extract of the present invention, it can exhibit a significantly greater effect than the hypoglycemic effect of the culture mycelium extract cultured using a conventional potato medium, can be widely used in functional foods for diabetic patients will be.

Claims (5)

건조분쇄한 귤피를 열수추출 및 여과하여 수득한 귤피 추출물 원액 2.0%(v/v), 포도당 5.0%(v/v), 효모추출물 0.5%(w/v), 펩톤 0.5%(w/v), 맥아추출물 0.3%(w/v) 및 정제수 91.7%(v/v)를 함유하고, pH가 5.0인 귤피 배지에, 2.0% (v / v) undiluted juice, 5.0% (v / v) glucose, 0.5% (w / v) yeast extract, 0.5% (w / v) yeast extract In a tangerine medium containing 0.3% (w / v) of malt extract and 91.7% (v / v) of purified water and having a pH of 5.0, 소나무잔나비버섯 균사체를 접종하여 30℃, 150rpm 조건의 진탕기에서 12일간 배양하고, 그 결과 얻어진 배양액을 중조(NaHCO3)로 pH 7.0으로 조정한 후 균질화하고 이를 40℃에서 1/20으로 감압 농축하여 얻은 귤피 배지를 이용한 소나무잔나비버섯 배양균사체 추출물과, Inoculated with pine mycelium mycelium mycelium and incubated for 12 days in a shaker at 30 ℃, 150rpm conditions, the resulting culture was adjusted to pH 7.0 with sodium bicarbonate (NaHCO 3 ), homogenized and concentrated under reduced pressure to 1/20 at 40 ℃ Pine myrtle mushroom culture mycelium extract using the obtained tangerine medium, 세절, 분쇄한 소나무잔나비버섯 자실체에 증류수를 가하고 냉각관을 부착한 추출조를 이용하여 24시간 동안 추출한 후, 1/4로 농축하여 얻은 소나무잔나비버섯 자실체 열수 추출물을 포함하며,  Distilled water was added to the shredded and crushed pine needles fruiting body and extracted for 24 hours using an extraction tank attached with a cooling tube, and then concentrated to 1/4. 상기 귤피 배지를 이용한 소나무잔나비버섯 배양균사체 추출물과, 상기 소나무잔나비버섯 자실체 열수 추출물의 중량비는 1 : 1인 혈당강하용 조성물. The pineapple butterfly mushroom culture mycelium extract using the tangerine medium, and the weight ratio of the pine tree butterfly mushroom fruiting body hydrothermal extract is 1: 1 composition for lowering blood sugar. 삭제delete 삭제delete 삭제delete 삭제delete
KR1020070034998A 2007-04-10 2007-04-10 Submerged-Liquid Culture Extract of Fomitopsis pinicola Mycelium and Composition Comprising the Same for Lowering Blood Sugar KR100859984B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1020070034998A KR100859984B1 (en) 2007-04-10 2007-04-10 Submerged-Liquid Culture Extract of Fomitopsis pinicola Mycelium and Composition Comprising the Same for Lowering Blood Sugar

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020070034998A KR100859984B1 (en) 2007-04-10 2007-04-10 Submerged-Liquid Culture Extract of Fomitopsis pinicola Mycelium and Composition Comprising the Same for Lowering Blood Sugar

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
KR1020060011691 Division 2006-02-07 2006-02-07

Publications (2)

Publication Number Publication Date
KR20070080606A KR20070080606A (en) 2007-08-10
KR100859984B1 true KR100859984B1 (en) 2008-09-25

Family

ID=38600910

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020070034998A KR100859984B1 (en) 2007-04-10 2007-04-10 Submerged-Liquid Culture Extract of Fomitopsis pinicola Mycelium and Composition Comprising the Same for Lowering Blood Sugar

Country Status (1)

Country Link
KR (1) KR100859984B1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102662439B1 (en) * 2016-01-29 2024-04-30 경희대학교 산학협력단 A composition comprising Fomitopsis pinicola for preventing or treating diabetes mellitus

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20050060726A (en) * 2003-12-17 2005-06-22 김천환 Hypoglycemics including fomitosis pinicola extraction and preparing method thereof

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20050060726A (en) * 2003-12-17 2005-06-22 김천환 Hypoglycemics including fomitosis pinicola extraction and preparing method thereof

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
한국식품저장유통학회지, 2005, 12(4), pp.379-386*

Also Published As

Publication number Publication date
KR20070080606A (en) 2007-08-10

Similar Documents

Publication Publication Date Title
Buswell et al. Edible mushrooms: attributes and applications
US6383799B1 (en) Process for producing, methods and compositions of glucuronoxylomannan as nutriceutical agent from higher basidiomycetes mushroom
US6197295B1 (en) Dietary supplementation with, and methods for administration of yeast-derived selenium product
US7790175B2 (en) Strain of turkey tail mushroom, extract from the same, and use of the same
KR101925890B1 (en) Novel strain of Ceriporia lacerata-K1, and composition comprising its culture for preventing or treating diabetes mellitus
CN102994305B (en) Method for preparing health-care food (therapy) product (nutrient juice wine) by use of extracts from cordyceps militaris and cocoon
KR101969433B1 (en) Composition comprising product of two stage cultivation using Ganoderma applanatum and Ceriporia lacerata K1 mycelium for preventing or treating diabetes mellitus
KR20140138490A (en) Fermented Sparassis crispa and method for preparing the same
Lo et al. Submerged culture mycelium and broth of Grifola frondosa improve glycemic responses in diabetic rats
KR20100012923A (en) Method of cultivating cordyceps sinensis and use of culture thereof
KR20170007905A (en) Manufacturing method of nutritious rice and nutritious rice
KR100859984B1 (en) Submerged-Liquid Culture Extract of Fomitopsis pinicola Mycelium and Composition Comprising the Same for Lowering Blood Sugar
JP2005213211A (en) Agent for inhibiting increase of blood glucose level
KR20030028638A (en) Method of producing a Healthy Mulberry Leaf Food by culture of Mushroom Mycelia
WO2007091827A1 (en) Extract from submerged culture of fomitopsis pinicola mycelia and hypoglycemic composition comprising the same
KR100534066B1 (en) Mushroom lactic acid fermented solution including effective ingredients for decreasing the value of blood sugar, and method for manufacturing the solution
CN112869156A (en) A method for preparing concentrated solution from Inonotus obliquus and birch juice
KR100859983B1 (en) Fomitopsis pinicola Extract Having Inhibitory Effect of Reactive Oxygen Spices Generated by Diabetes Mellitus and The Use Thereof
KR20080070417A (en) Mycelia and fruiting bodies of auricularia auricula-judae having hypolipidemic effect and method for preparing the same
KR20090098254A (en) Method for producing artemisia extract by fermentation
KR100859986B1 (en) Fomitopsis pinicola Extract Having Diabetes Complication Preventive Effect and The Use Thereof
KR20140072418A (en) Composition for Improving Obesity
KR20140024549A (en) Method for manufacturing functional mushroom rice
KR20070092188A (en) Promoted antidiabetic effect of red ginseng-chungkukjang fermented with submerged culture fomitopisis pinicola mycelium or its cultured broth
KR20240106990A (en) Beverage for improving palatability and liver function containing fermented Hovenia dulcis using Phellinus linteus and production method thereof

Legal Events

Date Code Title Description
A107 Divisional application of patent
A201 Request for examination
E902 Notification of reason for refusal
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 20120918

Year of fee payment: 5

FPAY Annual fee payment

Payment date: 20130916

Year of fee payment: 6

FPAY Annual fee payment

Payment date: 20140916

Year of fee payment: 7

FPAY Annual fee payment

Payment date: 20150916

Year of fee payment: 8

FPAY Annual fee payment

Payment date: 20170912

Year of fee payment: 10

FPAY Annual fee payment

Payment date: 20180917

Year of fee payment: 11

FPAY Annual fee payment

Payment date: 20190918

Year of fee payment: 12